ACE2 and COVID-19: In COVID-19 patients, autoantibodies against nuclear bodies (auto-nuclear antibodies—ANA), phospholipids, type I interferon (IFN), melanoma differentiation-associated protein 5 (MDA5), and ACE2 have been reported226.